X0306 4 2023-01-12 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001856371 Scanlan Sean F. C/O TREACE MEDICAL CONCEPTS, INC. 100 PALMETTO PARK PLACE PONTE VEDRA FL 32081 0 1 0 0 Chief Innovation Officer Common Stock 2023-01-12 4 M 0 25000 0.10 A 34975 D Common Stock 2023-01-12 4 S 0 25000 25.5723 D 9975 D Stock Option (Right to Buy) 0.10 2023-01-12 4 M 0 25000 0.10 D 2018-12-15 2024-12-15 Common Stock 25000 83750 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. Includes 9,975 RSUs. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $25.5000 to $25.7500 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan 2023-01-13